Janssen Pharmaceutica Nv

Huajun Lu

Michael P Wachter

Fina Liotta

Mingde Xia

Meng Pan

Mark J Macielag

Mingde Xie

This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.

Hexahydro-cycloheptapyrazole cannabinoid modulators

This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.

Hexahydro-cyclooctyl pyrazole cannabinoid modulators

This invention is directed to a tetrahydro-2H-indazole pyrazole cannabinoid modulator compound of formula (I): or a form thereof, wherein p, R, Rand Ar are as herein described and * represents a chiral center, and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.

Tetrahydro-2H-indazole pyrazole cannabinoid modulators

The invention relates to a CB modulator compound of Formula (I) or a pharmaceutically acceptable form thereof and a method for use in treating, ameliorating or preventing a CB receptor mediated syndrome, disorder or disease.

Growing community of inventors

Bridgewater, NJ, United States of America

Huajun Lu